Lethal Hyperammonemia due to Ornithine Transcarbamylase Deficiency in a Patient with Severe Septic Shock
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Severe hyperammonemia can occur as a result of inherited or acquired liver enzyme defects in the urea cycle, among which ornithine transcarbamylase deficiency (OTCD) is the most common form. We report a very rare case of a 45-year-old Korean male who was admitted to the intensive care unit (ICU) due to severe septic shock with acute respiratory failure caused by Pneumocystis jiroveci pneumonia. During his ICU stay with ventilator care, the patient suffered from marked hyperammonemia (>1,700 μg/dL) with abrupt mental change leading to life-threatening cerebral edema. Despite every effort including continuous renal replacement therapy and use of a molecular adsorbent recirculating system (extracorporeal liver support–albumin dialysis) to lower his serum ammonia level, the patient was not recovered. The lethal hyperammonemia in the patient was later proven to be a manifestation of acquired liver enzyme defect known as OTCD, which is triggered by serious catabolic conditions, such as severe septic shock with acute respiratory failure.
Abstract
Severe hyperammonemia can occur as a result of inherited or acquired liver enzyme defects in the urea cycle, among which ornithine transcarbamylase deficiency (OTCD) is the most common form. We report a very rare case of a 45-year-old Korean male who was admitted to the intensive care unit (ICU) due to severe septic shock with acute respiratory failure caused by Pneumocystis jiroveci pneumonia. During his ICU stay with ventilator care, the patient suffered from marked hyperammonemia (>1,700 μg/dL) with abrupt mental change leading to life-threatening cerebral edema. Despite every effort including continuous renal replacement therapy and use of a molecular adsorbent recirculating system (extracorporeal liver support–albumin dialysis) to lower his serum ammonia level, the patient was not recovered. The lethal hyperammonemia in the patient was later proven to be a manifestation of acquired liver enzyme defect known as OTCD, which is triggered by serious catabolic conditions, such as severe septic shock with acute respiratory failure.
참고문헌 (14)
- Gropman AL, "Neurological implications of urea cycle disorders", J Inherit Metab Dis, 30, pp.865~879 (2007)
- Shawcross D, "The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation", Cell Mol Life Sci, 62, pp.2295~2304 (2005)
- Vaquero J, "Pathogenesis of hepatic encephalopathy in acute liver failure", Semin Liver Dis, 23, pp.259~269 (2003)
- Clay AS, "Hyperammonemia in the ICU", Chest, 132, pp.1368~1378 (2007)
- Bachmann C, "Physicians Guide to the Laboratory Diagnosis of Metabolic Diseases", pp.261~276 (2003), Springer
- Brusilow SW, "The Metabolic and Molecular and Bases of Inherited Disease, 4 volume", pp.1909~1961 (2000), McGraw-Hill
- Yamaguchi S, "Mutations and polymorphisms in the human ornithine transcarbamylase (OTC) gene", Hum Mutat, 27, pp.626~632 (2006)
- Arranz JA, "Estimation of the total number of disease-causing mutations in ornithine transcarbamylase (OTC) deficiency. Value of the OTC structure in predicting a mutation pathogenic potential", J Inherit Metab Dis, 30, pp.217~226 (2007)
- Wakiya T, "Living donor liver transplantation for ornithine transcarbamylase deficiency", Pediatr Transplant, 15, pp.390~395 (2011)
- Yorifuji T, "X-inactivation pattern in the liver of a manifesting female with ornithine transcarbamylase (OTC) deficiency", Clin Genet, 54, pp.349~353 (1998)
- Gordon N, "Ornithine transcarbamylase deficiency: a urea cycle defect", Eur J Paediatr Neurol, 7, pp.115~121 (2003)
- Häberle J, "Suggested guidelines for the diagnosis and management of urea cycle disorders", Orphanet J Rare Dis, 7, pp.32~ (2012)
- Chiu A, "MARS treatment for a patient presenting with acquired hepatic glutamine synthetase deficiency after orthotopic liver transplantation", Liver Transpl, 11, pp.353~355 (2005)
- Busuttil AA, "The role of orthotopic liver transplantation in the treatment of ornithine transcarbamylase deficiency", Liver Transpl Surg, 4, pp.350~354 (1998)